Atlas FDA

Supartz Device Family

FDA premarket approval P980044/S037 · decided 2017-03-21

Approval details

PMA number
P980044
Supplement
S037
Supplement type
30-Day Notice
Supplement reason
Process Change - Manufacturer/Sterilizer/Packager/Supplier
Trade name
Supartz Device Family
Generic name
Acid, hyaluronic, intraarticular
Applicant
Seikagaku Corp.
Date received
2017-02-24
Decision date
2017-03-21
Days to decision
25 days
Decision code
OK30
Product code
MOZ
Advisory committee
Orthopedic
Expedited review
No
Location
Tokyo
Statement
Update microbiological incubators used for quality control testing and environmental monitoring of products for SUPARTZ FX and VISCO-3.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
HADGEL, 4 GRAM/SYRINGE (K011544)Seikagaku Corp.2001-08-15